BRIM Biotechnology, Inc. (TPE:6885)
Taiwan · Delayed Price · Currency is TWD 32.00
+1.00 (3.23%)
Sep 30, 2026, 1:30 PM CST
BRIM Biotechnology Market Cap
BRIM Biotechnology has a market cap or net worth of 4.12 billion as of September 29, 2026. Its market cap has decreased by -1.81% in one year.
Market Cap
4.12B
Enterprise Value
3.23B
Revenue
10.60M
Ranking
n/a
PE Ratio
n/a
Stock Price
32.00
ChartMarket Cap Chart
Since June 23, 2022, BRIM Biotechnology's market cap has increased from 1.77B to 4.12B, an increase of 133.58%. That is a compound annual growth rate of 21.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 29, 2026 | 4.14B | 4.42% |
| Dec 31, 2025 | 3.96B | -2.58% |
| Dec 31, 2024 | 4.07B | 17.34% |
| Dec 29, 2023 | 3.47B | -2.55% |
| Dec 30, 2022 | 3.56B | 101.45% |
| Jun 23, 2022 | 1.77B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Medigen Biotechnology | 5.26B |
| UnicoCell Biomed | 4.64B |
| Mycenax Biotech | 4.63B |
| Sinew Pharma | 4.28B |
| OBI Pharma | 4.27B |
| Pharmosa Biopharm | 4.11B |
| Formosa Pharmaceuticals | 3.85B |
| Great Novel Therapeutics Biotech & Medicals | 3.75B |